Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Synthesis, activity and use of new neovascularization inhibitors disclosed by Takeda

July 19, 2000

G-protein-targeted antisense oligonucleotides patented by Isis

July 19, 2000

Intranasal IM-862 effective and safe in patients with AIDS-related Kaposi's sarcoma

July 19, 2000

Tularik initiates phase II studies of T-64 for treatment of solid tumors

July 19, 2000

Novel nucleoside transport inhibitor NU-3108 deemed suitable for further development

July 18, 2000

Naturally produced antiangiogenic agent identified by Eisai and Mercian

July 18, 2000

NeoRx's STR product continues to show positive phase I/II results

July 18, 2000

Phase I Endostatin trial to enroll 12 additional patients

July 14, 2000

New series of psoralen-based photochemotherapeutics claimed by Buckman Laboratories

July 13, 2000

Genta begins follow-up studies of Genasense combination therapy for prostate cancer

July 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...